1.
Paul LK.
Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement.
Journal of Neurodevelopmental Disorders.
2011;3(1):3–27.
2.
Krupa K,
Bekiesinska-Figatowska M.
Congenital and Acquired Abnormalities of the Corpus Callosum: A Pictorial Essay.
Biomed Res Int.
2013;2013: 265619.
3.
Raybaud C.
The corpus callosum,
the other great forebrain commissures,
and the septum pellucidum: anatomy,
development,
and malformation.
Neuroradiology.
2010:52(6);447–77.
4.
Rubinstein D,
Youngman V,
Hise JH,
Damiano TR.
Partial development of the corpus callosum.
Am J Neuroradiol.
1994;15:869–75.
5.
Hanna RM,
Marsh SE,
Swistun D,
et al.
Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families.
Neurology.
2011;76(4):373–82.
6.
Ginat DT,
Meyers SP.
Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis.
RadioGraphics 2012;32:499–516.
7.
Mimouni-Bloch A.
Kornreich L.
Kaadan W.
Steinberg T.
Shuper A.
Lesions of the corpus callosum in children with neurofibromatosis 1.
Pediatric Neurology.
2008;38(6):406–10.
8.
Pride N,
Payne JM,
Webster R,
Shores EA,
Rae C,
North KN.
Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
Journal of Child Neurology.
2010; 25(7):834–41.
9.
Brant WE,
Helms CA.
Fundamentals of Diagnostic Radiology.
3rd ed.
Lippincott Williams & Wilkins; 2007.
10.
Prayson RA.
Neuropathology Review.
Humana Press.
2nd ed.
Humana Press; 2008.
11.
Cheon JE,
Kim IO,
Hwang YS,
Kim KJ,
et al.
Leukodystrophy in children: a pictorial review of MR imaging features.
Radiographics.
2002; 22(3):461–76.
12.
Sarbu N,
Shih RY,
Jones RV et al.
White Matter Diseases with Radiologic-Pathologic Correlation.
Radiographics.
2016;36(5):1426-47.
13.
Polman CH,
Reingold SC,
Banwell B,
et al.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Annals of Neurology. 2011;69(2):292–302.
14.
Bagnato F,
Jeffries N,
Richert ND,
et al.
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.
Brain.
2003;126:1782–9.
15.
Lassmann H.
The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Neuroimaging Clin N Am.
2008;18:563–76.
16.
Navarro JF,
Noriega S.
Marchiafava Bignami disease.
Rev Neurol 1999;28:519–23.
17.
Chang KH,
Cha SH,
Han MH.
Marchiafava-Bignami disease: serial changes in corpus callosum on MRI.
Neuroradiology 1992;34:480–2.
18.
Friese S,
Biltzer M,
Freudenstein D,
et al.
Classification of acquired lesions of the corpus callosum with MRI.
Neuroradiology 2000;42:795–802.
19.
Celik Y,
Kaya M,
Sengun S,
Utku U.
Marchiafava-Bignami disease: cranial MRI and SPECT findings.
Clin Neurol Neurosurg 2002;104:339–41.
20.
Yamamoto T,
Ashikanga R,
Araki Y,
Nishimura Y.
A case of Marchiafava-Bignami disease: MRI findings on spin-echo and attenuated inversion recovery (FLAIR) images.
Eur J Radiol 2000;34:141–143.
21.
Kawamura M,
Shiota J,
et al.
Marchiafava Bignami disease: computed tomographic scan and magnetic resonance imaging.
Ann Neurol 1985;18:103–4.
22.
Bourekas E,
Varakis K,
Bruns D,
et al.
Lesions of the corpus callosum: MR imaging and differential considerations in adults and children.
AJR Am J Roentgenol 2002;179:251–7.
23.
Ho ML,
Moonis G,
Ginat DT,
Eisenberg RL.
Lesions of the Corpus Callosum.
AJR Am J Roentgenol 2013;200:W1–W16.
24.
Brunereau L,
Labauge P,
Tournier-Lasserve E et-al.
Familial form of intracranial cavernous angioma: MR imaging findings in 51 families.
French Society of Neurosurgery.
Radiology.
2000;214 (1): 209-16.
25.
Zhu WZ,
Qi JP,
Zhan CJ,
et al.
Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage.
Chin.
Med.
J.
2008;121(20):2021-5.
26.
Pinker K,
Stavrou I,
Knosp E et-al.
Are cerebral cavernomas truly nonenhancing lesions and thereby distinguishable from arteriovenous malformations? MRI findings and histopathological correlation.
Magn Reson Imaging.
2006;24 (5): 631-7.
27.
Kleihues P,
Burger PC,
Collins VP,
Newcomb EW,
Ohgaki H,
Cavenee WK.
Glioblastoma.
In: Kleihues P,
Cavenee WK,
eds.
Pathology and genetics of tumors of the nervous system.
Lyon,
France: IARC,
2000; 29–39.
28.
Agrawal A.
Butterfly glioma of the corpus callosum.
Journal of Cancer Research and Therapeutics.
2009:5(1);43–5.
29.
Law M,
Yang S,
Wang H,
et al.
Glioma grading: sensitivity,
specificity,
and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
AJNR Am J Neuroradiol.
2003;24:1989–98.
30.
Stadlbauer A,
Gruber S,
Nimsky C,
et al.
Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Radiology.
2006;238(3):958–69.
31.
Broniscer A,
Chamdine O,
Hwang S,
Lin T,
Pounds S,
Onar-Thomas A,
Shurtleff S,
Allen S,
Gajjar A,
Northcott P et al.
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
Acta Neuropathol.
2016;131:299–307.
32.
Herrlinger U,
Jones DT,
Glas M,
Hattingen E,
Gramatzki D,
Stuplich M,
Felsberg J,
Bahr O,
Gielen GH,
Simon M et al.
Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Acta Neuropathol.
2016;131(2):309-19.
33.
Louis DN,
Perry A,
Reifenberger G.
von Deimling A,
Figarella-Branger D,
Cavenee WK,
Webster KC,
et al.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Acta Neuropathol.
2016;131:803–20.
34.
Sanson M,
Napolitano M,
Cartalat-Carel S,
et-al.
Gliomatosis cerebri.
Rev.
Neurol.
(Paris).
2005;161(2):173-81.
35.
Castillo M.
Neuroradiology Companion: Methods,
Guidelines,
and Imaging Fundamentals.
4rd ed.
Lippincott Williams & Wilkins; 2011.
36.
Chen S,
Tanaka S,
Giannini C et-al.
Gliomatosis cerebri: clinical characteristics,
management,
and outcomes.
J.
Neurooncol.
2013;112(2):267-75.
37.
Slone HW,
Blake JJ,
Shah R,
et al.
CT and MRI findings of intracranial lymphoma.
AJR 2005;184:1679–85.
38.
A.
Uchino,
Y.
Takase,
K.
Nomiyama,
R.
Egashira,
and S.
Kudo.
Acquired lesions of the corpus callosum: MR imaging.
European Radiology 2006;16(4):905–14.